Metyrapone

In the US, Metyrapone (metyrapone systemic) is a member of the following drug classes: adrenal corticosteroid inhibitors, in vivo diagnostic biologicals.

US matches:

• Metyrapone

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

V04CD01

CAS registry number (Chemical Abstracts Service)

0000054-36-4

Chemical Formula

C14-H14-N2-O

Molecular Weight

226

Therapeutic Category

Diagnostic agent, pituitary function

Chemical Name

1-Propanone, 2-methyl-1,2-di-3-pyridinyl-

Foreign Names

• Metyraponum (Latin)
• Metyrapon (German)
• Métyrapone (French)
• Metirapona (Spanish)

Generic Names

• Metyrapone (OS: USAN, JAN, BAN)
• Methopyrapone (IS)
• Su 4885 (IS)
• Metyrapone (PH: JP XIV, USP 30, BP 2010)

Brand Names

• Metopiron
  Novartis, Switzerland; Novartis, Japan



• Metopirone
  Alliance, United Kingdom; IFET, Greece; Novartis, Australia; Novartis, Ireland; Novartis, Israel; Novartis, New Zealand; Novartis, United States



• Métopirone
  Novartis, France

International Drug Name Search

Glossary

BAN	British Approved Name
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.